Sign in

CIK 0001706431 · Large accelerated filer

Vir Biotechnology, Inc.

Sign in to watch
Ticker
VIR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
812730369
Phone
415-906-4324
Business address
1800 OWENS STREET, SUITE 900, SAN FRANCISCO, CA, 94158
  1. 8-K Event Results of operations
  2. 4 Other disposition Director disposed of 1,196,540 shares (other)
  3. SC 13G/A Stake Amended Statement of Ownership
  4. 3 Insider Initial Statement of Ownership
  5. 3 Insider Initial Statement of Ownership
  6. 3 Insider Initial Statement of Ownership
  7. 4 Planned sale Director sold 12,190 shares at $7.80 ($95,032)
  8. 8-K Event Acquisition or sale completed · Executive or director change · Regulation FD disclosure
  9. 144 Insider Sale of Securities
  10. 10-Q Report Quarterly Report
  11. 8-K Event Results of operations · Exit or restructuring costs
  12. 8-K Event Material agreement
  13. 4 Grant or award EVP and Chief Medical Officer acquired 75,000 shares (grant or award)
  14. 144 Insider Sale of Securities
  15. 8-K Event Other events
  16. 4 Other disposition Chief Executive Officer disposed of 53,118 shares (other)
  17. 4 Open-market sale Director sold 4,000 shares at $10.95 ($43,789)
  18. 144 Insider Sale of Securities
  19. 144 Insider Sale of Securities
  20. 8-K Event Regulation FD disclosure

Page 11 of 41 · 806 filings